
Genepharm S.A.
Pallini, Greece genepharm.com From their website, Nov 2026
- GMP
- ISO 9001
Work here? Claim this listing
About
Genepharm S.A. develops, manufactures, and markets branded generic pharmaceutical products. It operates from Pallini, Attica, Greece and serves Greece, Europe, and worldwide markets through product development, out-licensing, sales, and distribution.
Services
Pharmaceutical development
Provides product realization from conception to submission, including formulation development and turn-key development solutions.
Formulation development
Develops conventional dosage forms and advanced technology platforms with QbD-based formulation and process development.
Analytical development
Develops analytical methods and supports method validation, transfer, formulation development, and process validation.
Control and release batch testing
Performs batch control and/or batch release for conventional and oncology products manufactured outside the EU.
Stability studies
Conducts stability studies under ICH-guided environmental conditions covering stability zones I, II, III, IVa, and IVb.
Regulatory affairs
Supports dossier compilation, eCTD sequences, submission via DCP/MRP, maintenance of marketing authorizations, and liaison with authorities.
Manufacturing
Manufactures conventional and oncological solid preparations on two advanced production lines.
Research and development
Upgrades research infrastructure to support specialized analyses, raw material and finished product quality assessment, and new formulation development.
2 more services
- Analytical R&D
- Batch control and batch release
Capabilities
- Assays and studies
- Stability studies
- Process development
- Analytical method development
- Method validation
- Method transfer
- Batch control
5 more
- Batch release
- Stability testing
- Specialized analyses
- Analytical method validation
- IVIVC studies
- Scale and capacity
- 12,000 m2 factory
- Two separate advanced production lines
- Conventional: 600M tablets, 40M capsules
- Oncology: 130M tablets, 10M capsules
- 12,000 m2 privately owned factory
- 2 separate advanced production lines
4 more
- Conventional: 600M tablets
- Conventional: 40M capsules
- Oncology: 130M tablets
- Oncology: 10M capsules
- Therapeutic areas
- Cardiology
- Diabetes
- Endocrinology
- Gastroenterology
- Hematology
- Neurology
6 more
- Oncology
- Orthopaedics
- Pathology
- Pulmonary hypertension
- Pulmonology
- Urology
Modalities and species
- Modalities
- Tablet
- Capsule
- Oral suspension
- Nasal spray
- Inhalation suspension
- Generic pharmaceuticals
3 more
- Oral solid dosage forms
- Conventional solids
- Oncology solids
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
ISO 9001Self-reported
Scope: quality system
Industries served
- Pharmaceuticals
Details
- Type
- CDMO
- Based in
- Pallini, Greece
- Sites
- Pallini, Attica, Greece
- Athens, Greece
- Serves
- Greece, Europe, worldwide, Greek market, international market, more than 90 countries
- Phone
- +30 210 603 9336
Public records
- Parent company
- ΑΝΩΝΥΜΟΣ ΧΗΜΙΚΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΕΙΑ GENEPHARM AE · GR GLEIF